Angiotensin II-induced myocardial fibrosis in rats: Role of nitric oxide, prostaglandins and bradykinin

Cardiovascular Research

Volumn 31, Issue 4, 1996, Pages 546-554

  Sigusch, Holger H ^a,b   Campbell, Scott E ^a   Weber, Karl T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

angiotensin II; Hoe140; indomethacin; L NAME; myocardial fibrosis; rat

Indexed keywords

ANGIOTENSIN; COLLAGEN; ICATIBANT; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOTENSIN II; ANIMALS; ARGININE; BRADYKININ; COLLAGEN; CYCLOOXYGENASE INHIBITORS; FIBROSIS; INDOMETHACIN; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ;

EID: 0029897702     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00214-6     Document Type: Article

References (58)

1. Wiener J, Lattes RG, Meltzer BG, Spiro D. The cellular pathology of experimental hypertension. IV. Evidence for increased vascular permeability. Am J Pathol 1969;54:187-207.
2. Wiener J, Giacomelli F. The cellular pathology of experimental hypertension. VII. Structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension. Am J Pathol 1973;72:221-240.
3. Bhan R.D, Giacomelli F, Wiener J. Ultrastructure of coronary arteries and myocardium in experimental hypertension. Exp Mol Pathol 1978;29:66-81.
4. Bhan RD, Giacomelli F, Wiener J. Adrenoreceptor blockade in angiotensin-induced hypertension: effect on rat coronary arteries and myocardium. Am J Pathol 1982;108:60-71.
5. Giacomelli F, Anversa P, Wiener J. Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol 1976;84:111-138.
6. Laine GA, Allen SJ. Left ventricular myocardial edema: lymph flow, interstitial fibrosis and cardiac function. Circ Res 1991;68:1713-1721.
7. Sun Y, Ratajska A, Zhou G, Weber KT. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 1993;122:395-403.
8. Ratajska A, Campbell SE, Cleutjens JPM, Weber KT. Angiotensin II and structural remodeling of coronary vessels in rats. J Lab Clin Med 1994;124:408-415.
9. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
10. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillman WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849-2861.
11. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820.
12. Reddy HK, Campbell SE, Janicki JS, Zhou G, Weber KT. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone and acute arterial hypertension. J Lab Clin Med 1993;121:510-521.
13. Sigusch HH, Ou R, Katwa LC, et al. Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. Cardiovasc Res 1995;30: 291-298.
14. Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995;27:1545-1560.
15. Reddy HK, Sigusch H, Zhou G, Tyagi SC, Janicki JS, Weber KT. Coronary vascular hyperpermeability and angiotensin II. J Lab Clin Med 1995;126:307-315.
16. Sun Y, Ratajska A, Weber KT. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 1995;27:813-822.
17. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 1990;67:1355-1364.
18. 2-receptors enhances the slow vasopressor response to angiotensin II. Hypertension 1994;23:646-652.
19. 2-receptor blockade facilitates deoxycorticosterone-salt hypertension. Hypertension 1993;21:980-984.
20. Campbell SE, Janicki JS, Matsubara BB, Weber KT. Myocardial fibrosis in the rat with mineralocorticoid excess: prevention of scarring by amiloride. Am J Hypertens 1993;6:487-495.
21. Arakawa K, Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'. Nature 1980;288:705-706.
22. Weber KT. Snakes and seaweed: a case of the swollen organ. Cardiovasc Res 1995;29:457-462.
23. Bareis DL, Manganiello VC, Hirata F, Vaughan M, Axelrod J. Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts. Proc Natl Acad Sci USA 1983;80:2514-2518.
24. Blumberg AL, Denny SE, Marshall GR, Needleman P. Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol 1977;232:H305-H310.
25. Conklin BR, Burch RM, Steranka LR, Axelrod J. Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J Pharmacol Exp Ther 1988;244:646-649.
26. Forstermann U, Hertting G, Neufang B.The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol 1986;87:521-532.
27. Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 1982;275:8630-8633.
28. 9-bradykinin. J. Biol. Chem 1984;259:9263-9268.
29. Roscher AA, Manganiello VC, Jelsema CL, Moss J. Receptors for bradykinin in intact cultured human fibroblasts. Identification and characterization by direct binding study. J Clin Invest 1983;72:626-635.
30. Stauss HM, Zhu YC, Redlich T, Unger T. Early and late treatment of infarction-induced heart failure with a converting enzyme inhibitor: bradykinin potentiation versus angiotensin II reduction. Hypotension 1993;22:429(Abstract).
31. Wiemer G, Scholkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-563.
32. Ratajska A, Campbell SE, Sun Y, Weber KT. Angiotenin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res 1994:28:684-690.
33. Wildhirt SM, Dudek RR, Suzuki H, Pinto V, Narayan KS, Bing RJ. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res 1995;29:256-231.
34. Reddy ST, Herschman HR, Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 1994;269:15473-15480.
35. Vane JR, Mitchell JA, Appleton I, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-2050.
36. Di Rosa M, Radomski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990;172:1246-1252.
37. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992;184:260-268.
38. Roscher AA, Manganiello VC, Jelsema CL, Moss J. Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formation in human fibroblasts. J Clin Invest 1984;74:552-558.
39. Carretero OA, Scicli AG. Kinins as regulators of blood flow and blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1990:805-817.
40. Nolly HL, Saed G, Scicli G, Carretero OA, Scicli AG. The kallikrein-kinin system in cardiac tissue. Agents Actions Suppl 1992;38(III):62-72.
41. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-1195.
42. Sun Y, Weber KT. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. J Lab Clin Med 1993;122:404-411.
43. Sappino AP, Schüren W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations Lab Invest 1990;63:144-161.
44. Reddy HK, Campbell SE, Zhou G, Tyagi S, Palma C, O'Sullivan F, Janicki JS, Weber KT. Acute elevations in angiotensin II result in rapid increases in the cardiac lymph levels of aldosterone, TGF-β and fibronectin. J Mol Cell Cardiol 1993;25(suppl III):S70(Abstract).
45. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-1432.
46. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 1994;28:1623-1628.
47. Katwa LC, Ratajska A, Cleutjens JPM, et al. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 1995;29:57-64.
48. Straus DS, Pang KJ. Effects of bradykinin on DNA synthesis in resting NIL8 hamster cells and human fibroblasts. Exp Cell Res 1984;151:87-95.
49. Myers SI, Evans CT, Inman L, et al. Acute cholecystitis potentiates bradykinin stimulated fibroblast prostanoid release in the rabbit. Mol Cell Endocrinol 1993;95:129-138.
50. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-12872.
51. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann NY Acad Sci 1994;744:50-57.
52. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 1992;267:7991-7994.
53. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 1991;60:281-319.
54. 1, augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J Cell Physiol 1994;159:67-75.
55. Campbell SE, Katwa LC, Weber KT. Transforming growth factor-β production in cardiac fibroblast-like cells [Abstract]. J Mol Cell Cardiol 1995;27:A6.
56. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431-2437.
57. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
58. Danckwardt L, Shimizu I, Bönner G, Rettig R, Unger T Converting enzyme inhibition in kinin-deficient Brown Norway rats. Hypertension 1990;16:429-435.